Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of Bone Height Gain Following Trans-crestal Sinus Floor Elevation Using the Densifying Bur in Comparison to The Conventional Osteotome In Patients With Atrophic Posterior Maxillae: A Randomized Controlled Clinical Trial

NCT05411510 is registered in ClinicalTrials.gov with Ahmed Mohamed Said Rozeik as lead sponsor.

NCT NCT05411510
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05411510 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of Bone Height Gain Following Trans-crestal Sinus Floor Elevation Using the Densifying Bur in Comparison to The Conventional Osteotome In Patients With Atrophic Posterior Maxillae: A Randomized Controlled Clinical Trial
Lead sponsor
Ahmed Mohamed Said Rozeik
Phase
Not applicable
Overall status
Unknown status
Start date
August 20, 2022
Completion date
December 20, 2023
Enrollment
20 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

maxillary sinus disease